The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade

BACKGROUND: Sugammadex is a novel neuromuscular reversal agent, but its associated hypersensitivity reaction and high cost have been obstacles to its widespread use. In the interest of reducing the necessary dosage of sugammadex, the reversal time of the combined use of sugammadex and neostigmine fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheong, Soon Ho, Ki, Seunghee, Lee, Jiyong, Lee, Jeong Han, Kim, Myoung-Hun, Hur, Dongki, Cho, Kwangrae, Lim, Se Hun, Lee, Kun Moo, Kim, Young-Jae, Lee, Wonjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Anesthesiologists 2015
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667139/
https://www.ncbi.nlm.nih.gov/pubmed/26634077
http://dx.doi.org/10.4097/kjae.2015.68.6.547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667139/
https://www.ncbi.nlm.nih.gov/pubmed/26634077
http://dx.doi.org/10.4097/kjae.2015.68.6.547

Ejemplares similares